Literature DB >> 15831533

Impaired voluntary running capacity of creatine kinase-deficient mice.

Iman Momken1, Patrick Lechêne, Nathalie Koulmann, Dominique Fortin, Philippe Mateo, Bich Thuy Doan, Jacqueline Hoerter, Xavier Bigard, Vladimir Veksler, Renée Ventura-Clapier.   

Abstract

The creatine kinase system (CK) is important for energy delivery in skeletal and cardiac muscles. The two main isoforms of this enzyme, cytosolic MM-CK and mitochondrial mi-CK, are expressed in a developmental and muscle-type specific manner. Mice deficient in one or both of these isoforms are viable and fertile but exhibit profound functional, metabolic and structural muscle remodelling that primarily affects fast skeletal muscles, which show an increased contribution of oxidative metabolism to contractile function. However, the consequences of these alterations in terms of physical capabilities have not yet been characterized. Consequently, we compared the voluntary exercise capacity of 9-month-old male wild-type (WT), M-CK knockout (M-CK(-/-)), and M-CK and mi-CK double knockout (CK(-/-)) mice, using cages equipped with running wheels. Exercise performance, calculated by total distance covered and by work done during the training period, was more than 10-fold lower in CK(-/-) mice than controls, with M-CK(-/-) mice exhibiting intermediate performance. Similarly, the mean distance run per activation was lower in M-CK(-/-) and even lower in CK(-/-) mice. However, the maximal running speed (V(max)) was lower only for CK(-/-) mice. This was accompanied by severe skeletal muscle mass decrease in CK(-/-) mice, with signs of histological damage that included enlarged interstitial areas, aggregations of mononuclear cells in the interstitium, heterogeneity of myofibre size and the presence of very small fibres. No overt sign of cardiac dysfunction was observed by magnetic resonance imaging during dobutamine stimulation. These results show that metabolic failure induced by CK deficiency profoundly affects the ability of mice to engage in chronic bouts of endurance running exercise and that this decrease in performance is also associated with muscle wasting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831533      PMCID: PMC1464549          DOI: 10.1113/jphysiol.2005.086397

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  56 in total

1.  Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ.

Authors:  L Kay; K Nicolay; B Wieringa; V Saks; T Wallimann
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

2.  Glycolysis supports calcium uptake by the sarcoplasmic reticulum in skinned ventricular fibres of mice deficient in mitochondrial and cytosolic creatine kinase.

Authors:  E Boehm; R Ventura-Clapier; P Mateo; P Lechène; V Veksler
Journal:  J Mol Cell Cardiol       Date:  2000-06       Impact factor: 5.000

3.  Cytoarchitectural and metabolic adaptations in muscles with mitochondrial and cytosolic creatine kinase deficiencies.

Authors:  K Steeghs; F Oerlemans; A de Haan; A Heerschap; L Verdoodt; M de Bie; W Ruitenbeek; A Benders; C Jost; J van Deursen; P Tullson; R Terjung; P Jap; W Jacob; D Pette; B Wieringa
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

4.  Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase.

Authors:  K W Saupe; M Spindler; R Tian; J S Ingwall
Journal:  Circ Res       Date:  1998-05-04       Impact factor: 17.367

5.  Is creatine kinase responsible for fatigue? Studies of isolated skeletal muscle deficient in creatine kinase.

Authors:  A J Dahlstedt; A Katz; B Wieringa; H Westerblad
Journal:  FASEB J       Date:  2000-05       Impact factor: 5.191

6.  Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction.

Authors:  Matthias Nahrendorf; Matthias Spindler; Kai Hu; Lisa Bauer; Oliver Ritter; Peter Nordbeck; Thomas Quaschning; Karl-Heinz Hiller; Julie Wallis; Georg Ertl; Wolfgang R Bauer; Stefan Neubauer
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

7.  Spectrum of aerobic endurance running performance in eleven inbred strains of rats.

Authors:  J C Barbato; L G Koch; A Darvish; G T Cicila; P J Metting; S L Britton
Journal:  J Appl Physiol (1985)       Date:  1998-08

8.  Functional coupling of creatine kinases in muscles: species and tissue specificity.

Authors:  R Ventura-Clapier; A Kuznetsov; V Veksler; E Boehm; K Anflous
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

9.  31P NMR studies of creatine kinase flux in M-creatine kinase-deficient mouse heart.

Authors:  F A Van Dorsten; M G Nederhoff; K Nicolay; C J Van Echteld
Journal:  Am J Physiol       Date:  1998-10

10.  Muscle unloading induces slow to fast transitions in myofibrillar but not mitochondrial properties. Relevance to skeletal muscle abnormalities in heart failure.

Authors:  A X Bigard; E Boehm; V Veksler; P Mateo; K Anflous; R Ventura-Clapier
Journal:  J Mol Cell Cardiol       Date:  1998-11       Impact factor: 5.000

View more
  29 in total

1.  Faster O₂ uptake kinetics in canine skeletal muscle in situ after acute creatine kinase inhibition.

Authors:  Bruno Grassi; Harry B Rossiter; Michael C Hogan; Richard A Howlett; James E Harris; Matthew L Goodwin; John L Dobson; L Bruce Gladden
Journal:  J Physiol       Date:  2010-11-08       Impact factor: 5.182

Review 2.  Cardiac system bioenergetics: metabolic basis of the Frank-Starling law.

Authors:  Valdur Saks; Petras Dzeja; Uwe Schlattner; Marko Vendelin; Andre Terzic; Theo Wallimann
Journal:  J Physiol       Date:  2006-01-12       Impact factor: 5.182

3.  Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology.

Authors:  Holger Lenz; Melanie Schmidt; Vivienne Welge; Thomas Kueper; Uwe Schlattner; Theo Wallimann; Hans-Peter Elsässer; Klaus-Peter Wittern; Horst Wenck; Franz Staeb; Thomas Blatt
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

4.  Unchanged mitochondrial organization and compartmentation of high-energy phosphates in creatine-deficient GAMT-/- mouse hearts.

Authors:  Jelena Branovets; Mervi Sepp; Svetlana Kotlyarova; Natalja Jepihhina; Niina Sokolova; Dunja Aksentijevic; Craig A Lygate; Stefan Neubauer; Marko Vendelin; Rikke Birkedal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

Review 5.  Heart failure: a model of cardiac and skeletal muscle energetic failure.

Authors:  B Mettauer; J Zoll; A Garnier; R Ventura-Clapier
Journal:  Pflugers Arch       Date:  2006-06-10       Impact factor: 3.657

Review 6.  Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.

Authors:  An M Van Berendoncks; Anne Garnier; Renée Ventura-Clapier; Viviane M Conraads
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

7.  Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice.

Authors:  F Caffin; A Prola; J Piquereau; M Novotova; D J David; A Garnier; D Fortin; M V Alavi; V Veksler; R Ventura-Clapier; F Joubert
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

8.  Quantitative trait loci for exercise training responses in FVB/NJ and C57BL/6J mice.

Authors:  Michael P Massett; Ruzong Fan; Bradford C Berk
Journal:  Physiol Genomics       Date:  2009-09-29       Impact factor: 3.107

9.  Phosphocreatine as an energy source for actin cytoskeletal rearrangements during myoblast fusion.

Authors:  Roddy S O'Connor; Craig M Steeds; Robert W Wiseman; Grace K Pavlath
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

10.  Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake.

Authors:  C I Nabuurs; C U Choe; A Veltien; H E Kan; L J C van Loon; R J T Rodenburg; J Matschke; B Wieringa; G J Kemp; D Isbrandt; A Heerschap
Journal:  J Physiol       Date:  2012-11-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.